// App-Quantinova.ai

P8 : A Rare Case of Complement Mediated Thrombotic Microangiopathy

Researchers

Presenter

  • K. Muralidharan

Principal Investigators

  • K. Nketiah Sarpong

  • K. Mathialagan

  • P. Pednekar

  • M. Rahi

  • M. Buscher

Medical Centers

  • Internal Medicine, Bridgeport Hospital, Bridgeport, CT, United States

  • Emergency Medicine/Critical Care, Bridgeport Hospital, Bridgeport, CT, United States

  • Pulmonary Diseases and Critical Care Medicine, Yale-New Haven Health Bridgeport Hospital, Bridgeport, CT, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Autoimmune (AI)

  • Cardiovascular (CVS)

  • Musculoskeletal

  • Blood/haematological Diseases

  • Central Nervous System (CNS)

  • Infectious Diseases (ID)

  • Genetic Disorder

  • Pulmonary/Respiratory Diseases

Disease

  • Antiphospholipid syndrome

  • Thrombotic thrombocytopenic purpura

  • Thrombotic microangiopathy

  • Transient Ischemic Attack

  • Hemolytic–uremic syndrome

  • Transient ischemic attack

  • Acute renal failure

  • Thrombocytopenia

  • Renal insufficiency

  • Septic shock

  • Venous thrombosis

  • Dyspnea

  • Anemia

  • Sepsis

Biomarkers

  • Creatinine

  • Serotonin

Drug/Treatment

  • Heparin

  • Eculizumab

  • Fibrinogen (IV)

  • Rituximab

  • Heparin

Outcome

  • N/A

Study Design

  • Cross-Sectional

  • Case report

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved